Important OptumRx updates to support providers, clinical staff and patients through COVID-19.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 22, 2019 - The FDA approved Aquestive Therapeutics’ Exservan (riluzole) oral film, for the treatment of amyotrophic lateral sclerosis (ALS).
Download PDF
Return to publications
